Connect with us

Legal & Regulation

Lobbyists Push to Legalize Marijuana Sales and Regulate the Market in DC

Published

on

Lobbyists Push to Legalize Marijuana Sales and Regulate the Market in DC

According to a recent Marijuana Moment report, leadership in the House and Senate received letters from over a dozen advocacy groups. The groups asked that a regulated marijuana market be implemented in D.C.

The groups, which include the Drug Policy Alliance, the ACULA of DC, NORML, and the Competitive Enterprise Institute, wrote that it is critical that Congress support D.C.’s right to a home rule and its ability to spend local tax dollars as the city sees fit.

The letter, which can be viewed here in full, indicates that the groups were writing on behalf of criminal justice reform and drug policy organizations. It further indicates that residents of the District of Columbia had voted to legalize marijuana for adult use in 2015. Even so, every year since then, Congress has prohibited D.C. from using funds to create a regulatory system for marijuana through an appropriations rider. And, current law has interfered with DC’s efforts to regulate marijuana, and this has had an impact on public safety.

The letter continues that there are over 700,000 residents in DC and Congress should follow the Home Rules Act and permit it to set its own local laws and to support its right to self-determination by lifting the rider prohibiting marijuana regulations.

Sian Fullerton is a Canadian scribe who has it easy. After being a professional writer and editor professionally on two continents in the last 15 trips around the sun, her passion is language and has created a career of being featured in front page newspapers, consumer health websites as well as polishing content for ABC radio broadcasting in Australia.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.